Literature DB >> 15745080

Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis.

Francesco Azzolini1, Cristiano Pagnini, Lorenzo Camellini, Antonella Scarcelli, Alberto Merighi, Anna Maria Primerano, Angela Bertani, Aldo Antonioli, Federico Manenti, Gian Piero Rigo.   

Abstract

Assessment of disease activity by clinical parameters in ulcerative colitis is still controversial. Different clinical indexes have been proposed. Colonoscopy provides detailed information on mucosal damage. The aim of this study was to identify, among 21 clinical and laboratory parameters, which were predictive of endoscopic activity. We included 137 consecutive patients with ulcerative colitis who underwent colonoscopy, clinical examination, and blood tests within 4 weeks. Endoscopic severity was recorded using a simple score (range, 0-30). The multiple stepwise regression coefficient of each significant variable predictive of mucosal damage was used to develop a new activity index predictive of endoscopic appearance (Endoscopic-Clinical Correlation Index; ECCI). We tested the ability of our score to discriminate patients with severe endoscopic disease, calculating the area under the receiver operator characteristic curve, and we compared it to activity indexes proposed by other authors. Endoscopic severity was significantly influenced by four parameters: bloody stool, nocturnal bowel movements, body temperature >37.5 degrees C, and serum albumin. The new scoring system was calculated as ECCI = {[serum albumin x (-26)] + (bloody stool x 17) + (nocturnal bowel movements x 16) + [fever (0 or 1) x 39]} + 107. The ECCI accurately identified patients with severe endoscopic disease in our sample (sensitivity = 81%, specificity = 95%). In conclusion, the ECCI should be useful in clinical practice because it is simple and strongly related to endoscopic activity.

Entities:  

Mesh:

Year:  2005        PMID: 15745080     DOI: 10.1007/s10620-005-1590-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

Review 1.  11. Appropriateness of colonoscopy: inflammatory bowel disease.

Authors:  F Froehlich; T Larequi-Lauber; J J Gonvers; R W Dubois; B Burnand; J P Vader
Journal:  Endoscopy       Date:  1999-10       Impact factor: 10.093

2.  VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES
Journal:  Br Med J       Date:  1964-01-11

3.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

Review 4.  Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee.

Authors:  A Kornbluth; D B Sachar
Journal:  Am J Gastroenterol       Date:  1997-02       Impact factor: 10.864

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

6.  Endoscopic and histological patchiness in treated ulcerative colitis.

Authors:  B Kim; J L Barnett; C G Kleer; H D Appelman
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

7.  Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Authors:  Magnus Simrén; Jenny Axelsson; Rolf Gillberg; Hasse Abrahamsson; Jan Svedlund; Einar S Björnsson
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

Review 8.  Inflammatory bowel disease and cancer.

Authors:  S H Itzkowitz
Journal:  Gastroenterol Clin North Am       Date:  1997-03       Impact factor: 3.806

9.  A simple clinical colitis activity index.

Authors:  R S Walmsley; R C Ayres; R E Pounder; R N Allan
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

10.  Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years.

Authors:  Z Maratka; J Nedbal; J Kociánová; J Havelka; J Kudrmann; J Hendl
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

View more
  2 in total

1.  Patient reported symptoms during an ulcerative colitis flare: a Qualitative Focus Group Study.

Authors:  Akbar K Waljee; Joel C Joyce; Patricia A Wren; Tahira M Khan; Peter D R Higgins
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-05       Impact factor: 2.566

2.  Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.

Authors:  Sun-Ho Lee; Min-Ju Kim; Kiju Chang; Eun Mi Song; Sung Wook Hwang; Sang Hyoung Park; Dong-Hoon Yang; Kyung-Jo Kim; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Byong Duk Ye
Journal:  BMC Gastroenterol       Date:  2017-10-23       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.